Effect of statins on blood pressure: Analysis on adverse events released by FDA

Clinical and Experimental Hypertension : CHE
Tao YouXiao-Dong Xie

Abstract

As a class of cholesterol-lowering drugs, statins have been reported to cause unexpected decrease in blood pressure (BP). However, most studies in this issue were subject to inadequate study design or very small sample size. The present study was designed to examine the BP-lowering effect of various statins. Here we retrieved 5.9 million clinical reports submitted to FDA Adverse Event Reporting System (FAERS) from 2004 to 2015. Meta-analysis was performed to estimate the overall reporting odds ratio (ROR) of hypotension adverse events concurrent with various statins (i.e., atorvastatin, simvastatin, and rosuvastatin). Comparing the reporting rate of hypotension event between statins and other drugs found that atorvastatin (pooled ROR = 1.26, adjusted p-value = 8.60 × 10-4) and simvastatin (pooled ROR = 1.94, adjusted p-value = 4.16 × 10-45) were significantly associated with reduction in BP. On the other hand, the association between rosuvastatin and hypotension was observed to be nonsignificant (adjusted p-value = 0.65). To our knowledge, this is the first pooled analysis on large-scale data of adverse events to identify the BP-lowering effect of statins. The results will contribute to the development of novel statin-based ant...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Feb 6, 1999·Journal of the American College of Cardiology·W H KaesemeyerR W Caldwell
Apr 25, 2000·Journal of Cardiovascular Pharmacology·C BorghiE Ambrosioni
Dec 15, 2000·European Journal of Clinical Investigation·G TonoloM Maioli
Feb 19, 2002·The Annals of Pharmacotherapy·Mohamed A Omar, James P Wilson
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Jul 31, 2002·The Journal of Clinical Hypertension·Claudio BorghiEttore Ambrosioni
Apr 26, 2003·Atherosclerosis. Supplements·Eva Istvan
Aug 3, 2004·Nature Reviews. Drug Discovery·Ted T Ashburn, Karl B Thor
Aug 19, 2004·Pharmacoepidemiology and Drug Safety·Kenneth J RothmanSusan T Sacks
Feb 21, 2007·Hypertension·Pasquale StrazzulloFrancesco P Cappuccio
May 1, 2007·Clinical Biochemistry·Irina Buhaescu, Hassane Izzedine
May 1, 2007·Cardiovascular Drugs and Therapy·Vineet ChopraErdal Cavusoglu
Apr 10, 2009·Pharmacoepidemiology and Drug Safety·Elisabetta PoluzziFabrizio De Ponti
Nov 18, 2009·American Journal of Therapeutics·Carlos A Feldstein
Apr 23, 2013·International Journal of Cardiology·Maciej BanachUNKNOWN Lipid and Blood Pressure Meta-Analysis Collaboration Group
Apr 26, 2013·The Journal of Clinical Hypertension·Alexandros BriasoulisFranz H Messerli
May 1, 2004·Current Therapeutic Research, Clinical and Experimental·Adriana BranchiDomenico Sommariva
Apr 3, 2015·Lancet·Neil R PoulterMark Caulfield
Dec 9, 2015·Journal of the American Medical Informatics Association : JAMIA·Taha A Kass-HoutRoselie A Bright

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.